Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
Alliance Newsletter: On Call Fall 2025 September 18, 2025
Specialty Docs Weigh-In on CY 2026 Medicare Physician Payment and Quality Proposals September 5, 2025
Specialtydocs Raise Concerns about The Biosimilar Red Tape Elimination Act (S.1954) August 29, 2025
Specialtydocs Support the Resident Physician Shortage Reduction Act August 6, 2025© 2025 Alliance of Specialty Medicine. All rights reserved. Website designed and developed by Orpheus, Inc..

